Rhodes Jason P's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Apr 30, 2026
- Accession no.
- 0001577014-26-000006
- Filed
- Apr 30, 2026
- Trade date
- Apr 28, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.18M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhodes Jason PCIK 0001577014 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Common Stock | SSaleDisposed | −59,870 | $18.38 | −$1,100,410.6 | 1,577,432 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −119,115 | $18.38 | −$2,189,333.7 | 4,939,489 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −1,170 | $18.38 | −$21,504.6 | 8,512 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −47,082 | $18.38 | −$865,367.16 | 1,158,944 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −26 | $19.00 | −$494 | 1,577,406 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −52 | $19.00 | −$988 | 4,939,437 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −1 | $19.00 | −$19 | 8,511 | Indirect | |
| Apr 28, 2026 | Common Stock | SSaleDisposed | −21 | $19.00 | −$399 | 1,158,923 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.